NLS Pharmaceutics Ltd. announced that it will receive $1,750,000 in funding on March 20, 2024. The company will issue common shares and warrants in the transaction. The company will issue securities pursuant to exemption provided under Regulation D.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.189 USD | -6.34% | -12.86% | -67.96% |
Jun. 28 | NLS Pharmaceutics Announces Registered Direct Offering, Private Placement of Shares, Warrants | MT |
Jun. 27 | Sector Update: Health Care Stocks Slipping Late Afternoon | MT |
1st Jan change | Capi. | |
---|---|---|
-67.96% | 7.59M | |
+18.97% | 45.34B | |
+41.98% | 40.42B | |
-10.06% | 37.92B | |
+31.15% | 31.75B | |
-7.79% | 27.71B | |
+13.32% | 26.52B | |
+43.05% | 13.96B | |
+31.28% | 12.44B | |
-7.41% | 11.26B |
- Stock Market
- Equities
- NLSP Stock
- News NLS Pharmaceutics AG
- NLS Pharmaceutics Ltd. announced that it expects to receive $1.75 million in funding